Forbes -
20 Oct 2014 19:48
When the company announces its third quarter earnings, we expect overall sales to remain under pressure owing to lingering concerns surrounding its da Vinci robotic surgical system and a reduction in the number of robot-assisted surgical procedures. We expect gross margins to decline further in the near term due to higher costs owing to overall lower production and the company's focus on new products such as the da Vinci Xi and da Vinci Sp (which have slightly lower margins). However, we expect ...
Share this Article
Comment on this Article
Please to comment